ANGII-induced muscle atrophy is associated with reduced local and systemic insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) levels (16, 17, 18, 19). Here, IGFBP3 is linked to muscle atrophy.